糖尿病是MASH进展的危险因素之一.
Sofiya Gancheva1, Michael Roden1, Laurent Castera2
1Department of Endocrinology and Diabetology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany; German Center for Diabetes Research (DZD e.V.), Partner Düsseldorf, München-Neuherberg, Germany.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 与炎症 (MASH) 在2型糖尿病 (T2D) 中恶化. 了解它们的相互作用对于针对代谢途径和肠道健康的新疗法至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的健康问题.
- 非酒精性脂肪肝炎 (MASH) 代表了MASLD的渐进性,炎症阶段.
- MASH经常与2型糖尿病 (T2D) 共存,导致肝脏和心血管状况较差.
研究的目的:
- 审查T2D和MASH之间的复杂相互作用.
- 探索驱动疾病进展的潜在机制.
- 讨论T2D相关MASH的潜在治疗策略.
主要方法:
- 文献综述侧重于代谢变化的协同效应.
- 分析涉及脂肪组织,肠道微生物群和肝脏变化的途径.
- 检查当前和新兴的治疗干预措施.
主要成果:
- 脂肪组织功能障碍和肠道失调症加剧肝损伤和胰岛素抵抗.
- 肝脏脂质积累,氧化应激和ER应激导致炎症和纤维化.
- 改变生活方式 (饮食,运动) 对于管理与T2D相关的MASH至关重要.
结论:
- 与T2D相关的MASH的治疗策略应解决代谢因素的相互联系.
- 抗高血糖药物,特别是那些向因克列受体的药物,显示出有前途.
- 甲状腺激素受体-β激素是MASH和相关纤维化的有效治疗方法.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Psychoneuroimmunology: Diabetes and Cancer
mTOR Signaling and Cancer Progression
The mTOR pathway or the...


